Explore our validated phytochemical services and high-purity active ingredient supply chain, designed to satisfy rigorous global regulatory frameworks including FDA, EMA, and NMPA standards.
High-throughput cellular and enzymatic assays targeting enzymatic inhibition, cellular metabolic viability, and molecular pathways for botanical active compounds.
Comprehensive chemometric evaluation determining bioactive density across geographic geotypes, phenological phases, and harvesting periods for optimized extraction yields.
Isolation and identification of alkaloids, flavonoids, terpenoids, and polyphenolic fractions utilizing metabolomics and target-specific bio-affinity fractionation.
Systemic animal models quantifying pharmacodynamics, metabolic clearance, LD50, sub-acute toxicity, and target organ bioavailability under strict compliance.
Method development and analytical validation for HPLC, HPTLC, and GC-MS fingerprints ensuring batch reproducibility and regulatory compliance across markets.
Comprehensive GCP-compliant human clinical trials for herbal new drug approvals (NDAs) and dietary supplement human efficacy substantiation packages.
Optimized extraction, crystallization, and continuous chromatography to produce high-purity bioactive isolates, standardized pastes, and spray-dried botanical powders.
End-to-end commercial production of active botanical formulas into oral liquids, softgels, vegetarian capsules, micro-tablets, and functional granules.
An analytical overview of the international botanical API market, supply chain reconfiguration, and China’s strategic transition from crude herbal processing to molecular-level phytochemical engineering.
The global active pharmaceutical and botanical ingredients market is undergoing unprecedented expansion, projected to surpass USD 340 billion by 2030 at a compound annual growth rate (CAGR) exceeding 6.8%. Driven by consumer demand for preventative healthcare, escalating chronic metabolic disorders, and stringent regulatory demands for clean-label, bio-origin therapeutics, pharmaceutical and nutraceutical innovators are moving away from petrochemical-derived synthetics. Today's commercial success hinges on active ingredients defined by quantifiable molecular targets rather than crude dry-weight plant ratios.
China represents more than 60% of the world's upstream raw botanical supply and botanical extraction capacity. However, the modern supply chain has evolved far beyond raw agricultural exports. As leading Chinese manufacturers embrace cGMP, ISO 17025, and FDA Botanical Drug Guidelines, the country has become the premier hub for contract research and development organizations (CROs) and contract development and manufacturing organizations (CDMOs). Integrating vast agro-ecological diversity with cutting-edge analytical instrumentation, China provides end-to-end scalability with significant cost efficiencies.
Our standardized, milestone-governed CRO & CDMO lifecycle eliminates clinical translation failure and guarantees batch-to-batch chemical reproducibility.
Identification of molecular fractions via target-directed screening, metabolomic fingerprinting, and affinity chromatography.
Deliverable: Sourcing & Compound Target DossierDetermination of origin-specific phytochemical concentrations across harvest cycles to lock in premium biomass provenance.
Deliverable: Geo-Authentication & Potency MapDevelopment and ICH Q2(R1) validation of HPLC, HPTLC, and GC-MS protocols for assay, residual solvents, and pesticides.
Deliverable: Fully Validated Quality StandardRefining solid-liquid extraction, continuous membrane filtration, resin adsorption, and crystallization to optimize economics.
Deliverable: Pilot Critical Process Parameters (CPPs)Safety verification encompassing Ames genotoxicity, acute oral LD50, sub-chronic repeated dose studies, and safety pharmacology.
Deliverable: Complete Preclinical Safety PackageExecution of human pharmacokinetic/pharmacodynamic trials and pilot batches transitioning directly into commercial manufacturing.
Deliverable: Commercial Batches & Clinical DossierEmpowering enterprise clients with end-to-end infrastructure: from early single-compound screening to commercial solid dosage and liquid bottling.
Plants contain alkaloids, polysaccharides, saponins, and many other bioactive compounds. Using our accumulated phytochemical data and analytical capacity, we identify which substances best deliver target effects and which plant sources contain them at the highest density.
The same species can vary widely in active-ingredient potency depending on growing region, harvest season, and plant part used. We quantify these variations so you can lock in the optimal origin and harvest window, establishing a high-yield, cost-effective sourcing strategy.
Validated test methods represent the cornerstone of quality control. We develop precise assay methods using HPTLC, HPLC, GC, and chromatographic fingerprinting, equipping your QC teams with reliable protocols to verify identity, purity, and batch-to-batch consistency.
Once an active compound is confirmed, production economics decide competitiveness. We optimize raw-material pretreatment, extraction parameters, purification resin selectivity, and drying methods to maximize purity and industrial scale-up yields.
Formulating raw actives into commercial consumer formats can cause bioavailability loss, poor dissolution, or organoleptic degradation. Our pharmaceutical formulation scientists resolve stability and solubility barriers to maintain therapeutic delivery.
Empirical safety must precede product commercialization. We conduct GLP-aligned acute toxicity (LD50), chronic toxicological profiling, Ames mutagenicity, and chromosomal aberration assays to support international regulatory submissions.
Cellular assays reveal biological mechanisms at a fraction of the cost of in vivo testing. In vitro assays evaluate glucose uptake, antioxidant cascades, anti-inflammatory cytokine modulation, and antiviral pathway interventions for rapid go/no-go decisions.
Animal disease models provide definitive preclinical substantiation of efficacy, metabolic clearance, and dose-response dynamics, creating robust documentation for functional foods, cosmetics, and botanical therapeutics.
From human pilot proof-of-concept trials for dietary supplements to multi-center Phase I, II, III, and post-market Phase IV clinical evaluations, we supply the statistical data required for New Drug Applications (NDA) and health claims.
Leveraging modern pharmacological insights and classical TCM compatibility frameworks, we design synergistic multi-component formulations with enhanced pharmacokinetic profiles, available as turnkey packages or individual modules.
Directly managed pilot plants and cGMP-certified commercial facilities supply active botanical compounds as concentrated liquids, spray-dried powders, standardized viscous extracts, and pure volatile essential oils under strict NDA protection.
End-to-end commercial development and manufacturing for consumer-ready formats: oral liquid tonics, softgels, hard gelatin/HPMC capsules, micro-tablets, and granules, guaranteed by stringent in-line quality controls and regulatory documentation.
Bridging pharmaceutical rigor with scalable production across functional foods, pharmaceutical development, and clinical cosmeceuticals.
Supplying batch-to-batch standardized extracts that ensure reproducible polyphenol, ginsenoside, and bioflavonoid concentrations. We provide human pilot trial documentation and solubility-enhanced powder forms that withstand industrial tableting, hot-water dissolution, and acidic beverage pasteurization.
Serving biopharma partners targeting FDA 21 CFR Part 314 botanical drug applications and EMA herbal monographs. We establish full chemical characterization, impurity profiling, degradation kinetics, and multi-component pharmacological mechanisms developed across our portfolio of 22 proprietary drug candidates.
Isolating ultra-pure botanical actives validated by in vitro epidermal penetration testing, transdermal Franz cell diffusion, and anti-inflammatory human skin patch panels. Optimized for cellular anti-aging, UV protection, barrier repair, and melanogenesis regulation without skin irritation.
Anticipating regulatory tightening and technological disruptions through artificial intelligence, green extraction chemistry, and hybrid synthetic biology.
Traditional Chinese Medicine formulas rely on multi-target synergies that were historically challenging to decouple. We utilize machine learning algorithms and computational molecular docking to simulate how complex multi-component active ingredients interact with human receptor networks, cutting target identification times from years to months.
International markets increasingly demand zero residual solvent residues. MedGence employs Supercritical Fluid Extraction (SFE-CO2), subcritical water extraction, and green flash chromatography, dramatically decreasing carbon emissions while ensuring no petrochemical solvents touch heat-sensitive bioactives.
Many of nature's most potent compounds (e.g., curcuminoids, berberine, quercetin) suffer from low intestinal permeability and rapid first-pass metabolism. Our formulation labs develop nano-liposomal encapsulations, cyclodextrin complexes, and self-emulsifying drug delivery systems (SEDDS) that multiply oral bioavailability up to 800%.
Our contract research and industrial CDMO production power over 100 distinguished state institutions, publicly traded conglomerates, and teaching hospitals.
Beijing Tongrentang Group
CR Sanjiu Medical
Sunflower Pharmaceutical
Livzon Pharma Group
Dihon Pharmaceutical
Golden Throat Holdings
Yangtzi River Pharma
Beihai Gofar Chuanshan
Humanwell Healthcare
SCIMYTH Pharma
Shandong Hanfang Pharma
Luoxin Pharmaceutical
Guangdong Zhongsheng
Brilliance & Abundance
Apeloa Pharmaceutical
Heng Chang Pharma
Baotou TCM
Kamp Medicine
Guangxi Santo Pharma
Kangshou Pharma
Jiangxi Juwang Pharma
Beijing Tcmages
Guizhou Ruihe Pharma
CR Jinchan Pharma
Kangmei Pharma
Tianjicaotang Pharma
Jiangxi Kingstone Unite
Shuguang Hospital TCM
Hunan Directly TCM Hospital
1st Hosp Hunan TCM
2nd Xiangya Hospital
2nd Hosp Hunan TCM
Zhuzhou TCM OrthopedicsEssential technical insights addressing regulatory dossiers, method validation, intellectual property, and scale-up timelines.
Review our technical specifications and initiate your confidential CRO/CDMO project scoping with our senior chemical engineering team.
Cell-based screening models for bioactivity verification, molecular targeting, and toxicity pre-evaluation.
Geographical provenance and harvest window chemometric profiling to maximize active yield efficiency.
High-throughput isolation and bio-fractionation of plant alkaloids, glycosides, and bio-polyphenols.
Systemic animal models evaluating in vivo metabolic clearance, LD50, sub-acute toxicity, and organ safety.
Orthogonal HPLC, GC, and HPTLC fingerprint validation ensuring multi-regional regulatory compliance.
Full GCP clinical trial programs supporting new drug registrations and clinical health claim substantiation.
Pilot-to-commercial extraction, chromatography separation, and crystallization of high-value active ingredients.
Commercial encapsulation, tableting, and liquid filling lines operating under strict international cGMP standards.
Engage our scientific directors for custom study scoping, compound sourcing feasibility, or CDMO commercial batch pricing. Non-disclosure agreements (NDAs) are executed prior to data transfer.
